Company / Net Income
Harmony Biosciences Holdings, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$158.7M
FY2025
5-year range
-$152.0M / $181.5M
FY2021-FY2025
Trend
+9.1%
vs FY2024
Sector context
#38 of 216
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s net income of $159M is higher than 82% of companies in the Health Care sector (FY2025). Improved from $129M to $159M over the past 2 years.
Based on SEC 10-K filings.
$159M in FY2025 with a 3-year CAGR of -4.4%. Top quartile in the Health Care sector.
Improved from $129M to $159M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 216This company $158.7M Sector average $454.1M
▼
-65.1% below sector average
Key checks
Key Insights
- 3-year CAGR of -4.4%, indicating a declining trend.
- In FY2025, net income increased 9.1% year-over-year.
- Ranks #38 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $158.7M | +9.1% |
| FY2024 | $145.5M | +12.9% |
| FY2023 | $128.9M | -29.0% |
| FY2022 | $181.5M | +219.4% |
| FY2021 | -$152.0M | +0.0% |
| FY2020 | -$152.0M | +0.0% |
| FY2019 | -$152.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026